She is hard to get a handle on,so this may be causing some here to be confused....
Firstly you need to step back and look at her over the last 3years...
-Firstly a cap raising via an exercise of options for $8mil(which is as economic as the company could make it)
-Positive HCV results in combination with int/rib
-Positive HIV results
-Positive HIV/HCV results
The trials were conducted on small groups of 12 or 24 patients
They have done some pretty handy groundwork on a shoestring budget to prove up efficacy and safety.
-Strong Patent Protection.
-These trials i believe were conducted using a diluted liquid,since then they have developed a tablet form which is more easily absorbed meaning they can lower the dose of BIT225 for the same result.
All this for less than $6million ... maybe the reason they don't have a hundred mil market cap is because they don't tap the market every 6months.
Ultimately I believe they are inching their way to a bigger deal one step at a time.
GL Holders.
She is hard to get a handle on,so this may be causing some here...
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
